Pasar al contenido principal

ESTRATEGIAS NOVEDOSAS Y ORIGINALES PARA MEJORAR EL CONTROL DE LA PESTE PORCINA AFRICANA BASADAS EN EXPERIENCIAS (EXITOSAS Y NO EXITOSAS) PREVIAS

PID2022-136312OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES (IRTA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 21
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2

  • Marín Moraleda, David
  • Muñoz-Basagoiti, Jordana|||0000-0002-0384-5928
  • Tort-Miró, Aida
  • Navas, María Jesús
  • Muñoz, Marta
  • Vidal Barba, Enric|||0000-0002-4965-3286
  • Cobos, Àlex|||0009-0005-7308-4035
  • Martín-Mur, Beatriz|||0000-0002-6006-3295
  • Meas, Sochanwattey
  • Motuzova, Veronika
  • Chang, Chia-Yu
  • Gut, Marta|||0000-0002-4063-7159
  • Accensi Alemany, Francesc|||0000-0001-9068-0377
  • Pina-Pedrero, Sonia|||0000-0001-5475-4770
  • Núñez, J. Ignacio|||0000-0001-9890-7695
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Gavrilov, Boris|||0000-0001-9063-9200
  • Rodriguez, Fernando|||0000-0001-7361-8408
  • Liu, Lihong|||0000-0002-5921-6805
  • Argilaguet, Jordi|||0000-0001-5924-2774
African swine fever (ASF) is a deadly disease of swine currently causing a worldwide pandemic, leading to severe economic consequences for the porcine industry. The control of disease spread is hampered by the limitation of available effective vaccines. Live attenuated vaccines (LAVs) are currently the most advanced vaccine prototypes, providing strong protection against ASF. However, the significant advances achieved using LAVs must be complemented with further studies to analyze vaccine-induced immunity. Here, we characterized the onset of cross-protective immunity triggered by the LAV candidate BA71ΔCD2. Intranasally vaccinated pigs were challenged with the virulent Georgia 2007/1 strain at days 3, 7 and 12 postvaccination. Only the animals vaccinated 12 days before the challenge had effectively controlled infection progression, showing low virus loads, minor clinical signs and a lack of the unbalanced inflammatory response characteristic of severe disease. Contrarily, the animals vaccinated 3 or 7 days before the challenge just showed a minor delay in disease progression. An analysis of the humoral response and whole blood transcriptome signatures demonstrated that the control of infection was associated with the presence of virus-specific IgG and a cytotoxic response before the challenge. These results contribute to our understanding of protective immunity induced by LAV-based vaccines, encouraging their use in emergency responses in ASF-affected areas.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inactivated Rothia nasimurium promotes a persistent antiviral immune status in porcine alveolar macrophages

  • Tort-Miró, Aida
  • Alonso, Uxía
  • Martín-Mur, Beatriz|||0000-0002-6006-3295
  • Muñoz-Basagoiti, Jordana|||0000-0002-0384-5928
  • Zeng, Yan
  • Marín Moraleda, David
  • Ezcurra, Enrique
  • Montaner Tarbes, Sergio|||0000-0002-7664-3382
  • Navas, María Jesús
  • Muñoz, Marta
  • Monleón, Paula
  • González-Oliver, Judith
  • Cano, Esmeralda
  • Vilalta, Carles|||0000-0002-9220-8620
  • Caballé, Marc
  • Criado Mesas, Lourdes|||0000-0002-1115-4131
  • Kochanowski, Karl|||0000-0002-1884-7694
  • Accensi Alemany, Francesc|||0000-0001-9068-0377
  • Aragón, Virginia|||0000-0002-3470-6015
  • Correa-Fiz, Florencia|||0000-0002-9459-5871
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Rodríguez Rey, Fernando
  • Argilaguet, Jordi|||0000-0001-5924-2774
Globalization has increased the incidence of infectious diseases in livestock, further aggravated by the reduction of antibiotic usage. To minimize the resulting economic consequences to the meat production industry, as well as the risk of zoonotic events, the use of immunostimulants has emerged as a potential strategy to enhance animal resilience to diseases. In particular, the capability of bacterial-based immunostimulants to modulate innate immune cells functionality makes them cost-effective candidates as vaccine adjuvants, antimicrobials, or preventive immunostimulators inducing long-term innate immune memory in livestock. However, further research is required to identify novel bacterial strains with immunostimulatory properties. Here we characterized in vitro the immunostimulatory properties of Rothia nasimurium isolated from warthog fecal microbiota. Stimulation with heat-inactivated Rothia induced cytokine production by porcine immune cells, and a robust innate immune transcriptomic signature in porcine alveolar macrophages. Interestingly, the bacteria induced inflammasome activation and IL-1β production, thus confirming its pro-inflammatory properties, and suggesting its potential as vaccine adjuvant. Importantly, this immunostimulatory status functionally resulted in an antimicrobial state, enhancing the phagocytic capability of alveolar macrophages, and hampering the replication levels of two major porcine viral pathogens: the porcine reproductive and respiratory syndrome virus (PRRSV) and the African swine fever virus (ASFV). Moreover, macrophages showed an enhanced cytokine response upon ASFV infection several days after heat-inactivated Rothia stimulation, suggesting the induction of an innate immune memory phenotype. This nonspecific response resulted in a significant reduction of ASFV replication kinetics, demonstrating the capacity of the bacteria to induce a more resistant state in macrophages against a virus infection. Altogether, these results demonstrate the immunostimulatory capability of heat-inactivated R. nasimurium in porcine macrophages, showing potential to enhance animal resilience to diseases through the modulation of innate immune cells responsiveness to infections.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Inactivated Rothia nasimurium promotes a persistent antiviral immune status in porcine alveolar macrophages

  • Tort Miró, Aida
  • Alonso, Uxía
  • Martín-Mur, Beatriz
  • Muñoz Basagoiti, Jordana
  • Zeng, Yan
  • Marín-Moraleda, David
  • Ezcurra, Enrique
  • Montaner Tarbes, Sergio
  • Navas, María J.
  • Muñoz, Marta
  • Monleón, Paula
  • González-Oliver, Judith
  • Cano, Esmeralda
  • Vilalta, Carles
  • Caballé, Marc
  • Criado, Lourdes
  • Kochanowski, Karl
  • Accensi, Francesc
  • Aragon, Virginia
  • Correa-Fiz, Florencia
  • Esteve-Codina, Anna
  • Rodriguez, Fernando
  • Argilaguet, Jordi
Globalization has increased the incidence of infectious diseases in livestock, further aggravated by the reduction of antibiotic usage. To minimize the resulting economic consequences to the meat production industry, as well as the risk of zoonotic events, the use of immunostimulants has emerged as a potential strategy to enhance animal resilience to diseases. In particular, the capability of bacterial-based immunostimulants to modulate innate immune cells functionality makes them cost-effective candidates as vaccine adjuvants, antimicrobials, or preventive immunostimulators inducing long-term innate immune memory in livestock. However, further research is required to identify novel bacterial strains with immunostimulatory properties. Here we characterized in vitro the immunostimulatory properties of Rothia nasimurium isolated from warthog fecal microbiota. Stimulation with heat-inactivated Rothia induced cytokine production by porcine immune cells, and a robust innate immune transcriptomic signature in porcine alveolar macrophages. Interestingly, the bacteria induced inflammasome activation and IL-1β production, thus confirming its pro-inflammatory properties, and suggesting its potential as vaccine adjuvant. Importantly, this immunostimulatory status functionally resulted in an antimicrobial state, enhancing the phagocytic capability of alveolar macrophages, and hampering the replication levels of two major porcine viral pathogens: the porcine reproductive and respiratory syndrome virus (PRRSV) and the African swine fever virus (ASFV). Moreover, macrophages showed an enhanced cytokine response upon ASFV infection several days after heat-inactivated Rothia stimulation, suggesting the induction of an innate immune memory phenotype. This nonspecific response resulted in a significant reduction of ASFV replication kinetics, demonstrating the capacity of the bacteria to induce a more resistant state in macrophages against a virus infection. Altogether, these results demonstrate the immunostimulatory capability of heat-inactivated R. nasimurium in porcine macrophages, showing potential to enhance animal resilience to diseases through the modulation of innate immune cells responsiveness to infections., The author(s) declare that financial support was received for the research and/or publication of this article. This work is part of the projects PDC2021-120987-I00 (FR) and PID2022-136312OB-I00 (FR&JA), both funded by the MCIN/AEI/10.13039/501100011033/FEDER, UE. YZ is supported by a fellowship from the China Scholarship Council Visiting Scholar Program (202305960008). Institutional support to CNAG was provided by the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, and by the Generalitat de Catalunya through the Departament de Salut and the Departament de Recerca i Universitats. KK is supported by funding from the Spanish Ministry of Research and Innovation (RYC2021-033035-I/AEI/10.13039/501100011033)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus

  • Marín-Moraleda, David
  • Tort-Miró, Aida
  • Ezcurra, Enrique
  • Montaner Tarbes, Sergio
  • Muñoz Basagoiti, Jordana
  • Coatu, Elena
  • Navas, María Jesús
  • Muñoz, Marta
  • Monleon, Paula
  • González-Oliver, Judith
  • Pailler García, Lola
  • Pina-Pedrero, Sonia
  • Accensi, Francesc
  • Rodriguez, Fernando
  • Argilaguet, Jordi
Limited understanding of African swine fever (ASF) immunity remains a major barrier to the rational development of safe and effective vaccines. While antibody-mediated protection is still poorly defined, growing evidence highlights a central role for cellular immunity, particularly cytotoxic cells, as components associated with ASF virus (ASFV) infection control. However, the contribution of individual cytotoxic subsets across different virological and immunological contexts is not well characterized. Here, we investigated cytotoxic responses during BA71ΔCD2 live attenuated vaccine-induced protection and during late-stage lethal ASFV infection. Protective immunity was characterized by antigen-specific cytotoxic T-cell responses, whereas acute ASF was associated with broad cytotoxic activation. Early increases in perforin-positive CD4-CD8αβ+ T cells coincided with the onset of protection, and elevated recall responses correlated with survival following lethal challenge, supporting their association with protective immunity. Additional correlates of protection included CD4+CD8αβ+ cytotoxic T cells, IFNγ-producing cells, and specific antibodies, illustrating the multifactorial nature of protective immunity. In contrast, pigs with acute ASF showed broad cytotoxic expansion, perforin-positive natural killer and γδ T cells showing the strongest association with viremia. Together, these findings advance our understanding of cytotoxic responses to ASFV and identify perforin-positive T cells, alongside complementary immune components, as potential correlates of protection for future vaccine development., This work was funded by the Spanish Ministry of Science and Innovation, MICIU/AEI/10.13039/501100011033, grant PID2022-136312OB-I00 (J.A.)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Cloning and Expression of a Truncated Form of the p72 Protein of the African Swine Fever Virus (ASFV) for Application in an Efficient Indirect ELISA System

  • Cuevas-Romero, Julieta Sandra
  • Zavala-Ocampo, Perla Lucero
  • Pina-Pedrero, Sonia
  • Ganges, Llilianne
  • Muñoz-Aguilera, Adriana
  • García-Cambrón, José Bryan
  • Rodriguez, Fernando
  • Ambagala, Aruna
  • Cerriteño-Sánchez, José Luis
African swine fever (ASF) is a disease that affects both domestic and wild swine. It was recently reported in the Dominican Republic and Haiti (2021), representing a substantial risk to America. The goal of this study was to produce a truncated form of the ASF-p72 recombinant protein based on the ASF strain genotype II (Georgia 2017) as well as to develop and validate a sensitive and specific ASF indirect-ELISA (iELISA) for early detection of ASF. The truncated ASF-p72 recombinant protein was successfully expressed in E. coli BL21/DE3 cells using the pET-SUMO plasmid. Bioinformatics analysis showed 100% homology among the new isolates of ASFV from genotype II. The ASF-p72-truncated protein was used to develop an iELISA, which had a high sensitivity (88%) and strong specificity (97%); the concordance index kappa was K = 0.872, indicating nearly perfect agreement compared to the WOAH confirmatory immunoperoxidase test. The validation results utilizing the reference sera panel from the OIE-ASF Reference Laboratory show the excellent detection capabilities of ASF antibodies up to a 1:1000 serum dilution. The inter-assay coefficient of variation (CV 10.4%) and intra-assay CV (2.8%) data show that the assay is precise and reproducible. This biotechnology advancement can be used to conduct future epidemiological research for ASF surveillance in ASF-free American countries., This research was funded by PROCINORTE Project 2023 (INIFAP-CENID-SAI SIGI 154626612) and the Spanish Ministry of Science and Innovation (grant reference PID2022-136312OB-I00 to F.R.)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Genetically Distinct African Swine Fever Virus Genotype II Variant in Wild Boar, Spain, 2025–2026

  • Gallardo, Carmina
  • Marcet-Houben, Marina
  • Agüero, Montserrat
  • Nieto, Raquel
  • Casado, Nadia
  • Soler, Alejandro
  • Ruano, María José
  • Villalba, Rubén
  • Fernández-Pinero, Jovita
  • Simón, Alicia
  • Pérez, Covadonga
  • Gómez, Concepción
  • García, Cecilia
  • Labrador, Mireia
  • Argilaguet, Jordi
  • Coronado, Liani
  • Majo, Natalia
  • Aguilera-Sepulveda, Pilar
  • Aldea, Irene
  • Gabaldón, Toni
  • Gómez, María Belén
  • Arias, Marisa
African swine fever virus genotype II was detected in wild boar in Spain in 2025 after >30 years of absence. Whole-genome sequencing and molecular follow-up of 8 representative cases identified a stable 9.8-kb deletion affecting the multigene family in the left variable region, defining an ASFV genotype II variant., This work was supported by the European Union Reference Laboratory for African swine fever (grant no. 101198164, EURL-ASF 2025–2027) and the Spanish Ministry of Science and Innovation (MICIU/AEI/10.13039/501100011033), grant PID2022-136312OB-I00., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Nanoparticle-Based Secretory Granules Induce a Specific and Long-Lasting Immune Response through Prolonged Antigen Release

  • Bosch Camós, Laia
  • Martínez-Torró, Carlos
  • López-Laguna, Hèctor
  • Lascorz, Jara
  • Argilaguet, Jordi
  • Villaverde, Antonio
  • Rodriguez, Fernando
  • Vázquez, Esther
Developing prolonged antigen delivery systems that mimic long-term exposure to pathogens appears as a promising but still poorly explored approach to reach durable immunities. In this study, we have used a simple technology by which His-tagged proteins can be assembled, assisted by divalent cations, as supramolecular complexes with progressive complexity, namely protein-only nanoparticles and microparticles. Microparticles produced out of nanoparticles are biomimetics of secretory granules from the mammalian hormonal system. Upon subcutaneous administration, they slowly disintegrate, acting as an endocrine-like secretory system and rendering the building block nanoparticles progressively bioavailable. The performance of such materials, previously validated for drug delivery in oncology, has been tested here regarding the potential for time-prolonged antigen release. This has been completed by taking, as a building block, a nanostructured version of p30, a main structural immunogen from the African swine fever virus (ASFV). By challenging the system in both mice and pigs, we have observed unusually potent pro-inflammatory activity in porcine macrophages, and long-lasting humoral and cellular responses in vivo, which might overcome the need for an adjuvant. The robustness of both innate and adaptive responses tag, for the first time, these dynamic depot materials as a novel and valuable instrument with transversal applicability in immune stimulation and vaccinology., This project was mainly funded by the proof-of-concept project NANOSWINE, granted by UAB-Generalitat de Catalunya to E.V. and A.V. The authors are indebted to the Agencia Española de Investigación (AEI) for granting projects on the construction of protein materials of clinical interest (PID2019-105416RB-I00/AEI/10.13039/501100011033 and PDC2022-133858-I00 to E.V. and PID2020-116174RB-I00 to A.V.), to AGAUR for project SGR 2021 00092 to A.V., and to the Spanish Ministry of Science and Innovation (grant reference PID2022-136312OB-I00 to FR). C.M.-T. was supported by a Margarita Salas grant from Universitat Autònoma de Barcelona and Ministerio de Universidades (funded by the European Union—NextGenerationEU). We also appreciate the support from CIBER—Consorcio Centro de Investigación Biomédica en Red (CB06/01/0014), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, and Red de Investigación en Sanidad Animal (RISA). A.V. received an ICREA ACADEMIA award. The production of the therapeutic proteins was assisted, in part, by the Protein Production (PPP) Unit of the ICTS Nanbiosis Platform of the CIBER-BBN/IBB (http://www.nanbiosis. es/unit/u1-protein-production-platform-ppp/, accessed on 28 January 2024)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2

  • Marín-Moraleda, David
  • Muñoz-Basagoiti, Jordana
  • Tort-Miró, Aida
  • Navas, María Jesús
  • Muñoz, Marta
  • Vidal, Enric
  • Cobos, Àlex
  • Martín-Mur, Beatriz
  • Meas, Sochanwattey
  • Motuzova, Veronika
  • Chang, Chia-Yu
  • Gut, Marta
  • Accensi, Francesc
  • Pina-Pedrero, Sonia
  • Núñez, José Ignacio
  • Esteve-Codina, Anna
  • Gavrilov, Boris
  • Rodriguez, Fernando
  • Liu, Lihong
  • Argilaguet, Jordi
African swine fever (ASF) is a deadly disease of swine currently causing a worldwide pandemic, leading to severe economic consequences for the porcine industry. The control of disease spread is hampered by the limitation of available effective vaccines. Live attenuated vaccines (LAVs) are currently the most advanced vaccine prototypes, providing strong protection against ASF. However, the significant advances achieved using LAVs must be complemented with further studies to analyze vaccine-induced immunity. Here, we characterized the onset of cross-protective immunity triggered by the LAV candidate BA71ΔCD2. Intranasally vaccinated pigs were challenged with the virulent Georgia 2007/1 strain at days 3, 7 and 12 postvaccination. Only the animals vaccinated 12 days before the challenge had effectively controlled infection progression, showing low virus loads, minor clinical signs and a lack of the unbalanced inflammatory response characteristic of severe disease. Contrarily, the animals vaccinated 3 or 7 days before the challenge just showed a minor delay in disease progression. An analysis of the humoral response and whole blood transcriptome signatures demonstrated that the control of infection was associated with the presence of virusspecific IgG and a cytotoxic response before the challenge. These results contribute to our understanding of protective immunity induced by LAV-based vaccines, encouraging their use in emergency responses in ASF-affected areas., This research was funded by the Spanish Ministry of Science and Innovation, MICIU/AEI/10.13039/501100011033, grant PID2022-136312OB-I00 (F.R. and J.A.), and the Swedish Research Council for Sustainable Development (FORMAS), grant 2017-00486 (F.R. and L.L.)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Development and Standardization of Indirect ELISA for African Swine Fever Virus Using Recombinant p30 Protein Produced in Prokaryotic System

  • Cerriteño-Sánchez, José Luis
  • García-Cambrón, José Bryan
  • Zavala-Ocampo, Perla Lucero
  • Ganges, Llilianne
  • Cuevas-Romero, Julieta Sandra
African Swine Fever (ASF), caused by the African Swine Fever Virus (ASFV), is a highly contagious hemorrhagic disease with high mortality (≈100%) in pigs and is considered the most devastating disease to date. Given the importance of this disease, we aimed to assess the use of the recombinant p30 protein as the sole antigen for the development of an accurate and precise ELISA test (iELISA) for the virus. The recombinant p30 protein (rp30) was produced in a bacterial expression system using a SUMO-tagged expression vector. Protein expression was confirmed by Western blot analysis and purified using affinity chromatography. Antigenicity was evaluated in CF-1 mice, which demonstrated the ability to generate high levels of specific antibodies. The rp30 showed a sensitivity of 95.6% when used in the development of iELISA, a specificity of 92.3%, and a kappa index (κ) of 0.836. Furthermore, reference sera (OIE-ASF) were used to validate the assays, and the results demonstrated an excellent capacity to detect ASF antibodies using only the rp30 antigen up to a serum dilution of 1:100. The inter- and intra-assay variability coefficients were 4.27% and 4.85%, respectively, demonstrating that the assay was accurate and reproducible, allowing its use in seroepidemiological analyses for ASF surveillance., This research was funded by PROCINORTE (CENID-Salud Animal e inocuidad/INIFAP grant number: 154626612) and the MICIU (PID2022-136312OBI00)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus

  • Tort-Miró, Aida
  • Montaner Tarbes, Sergio
  • Marín-Moraleda, David
  • Muñoz Basagoiti, Jordana
  • Zeng, Yan
  • Navas, María Jesús
  • Muñoz, Marta
  • Monleon, Paula
  • González-Oliver, Judith
  • Martín-Mur, Beatriz
  • Caballé, Marc
  • Artigues, Margalida
  • Esteve-Codina, Anna
  • Aragon, Virginia
  • Vidal, Enric
  • Cobos, Àlex
  • Accensi, Francesc
  • Pina-Pedrero, Sonia
  • Garcia-Fruitos, Elena
  • Rodriguez, Fernando
  • Argilaguet, Jordi
While effective subunit vaccines against African swine fever (ASF) are still under development, live attenuated vaccines (LAVs) remain the only approach capable of inducing robust protective immunity, though biosafety concerns limit their field use. Thus, further research is required to improve LAV safety while maintaining its immunogenicity. Because both the ASF virus (ASFV) and derived LAVs suppress macrophage innate responses, we hypothesized that adjuvants could restore functionality of LAV-infected cells, allowing dose reduction and consequently minimizing the risk of adverse events. To test this, we intranasally vaccinated pigs with a suboptimal dose of the LAV BA71ΔCD2, either alone or combined with two immunostimulatory adjuvants derived from Rothia nasimurium. Both immunostimulants enhanced the in vitro responsiveness of BA71ΔCD2-infected macrophages, which acquired antigen-presenting features. However, in vivo, both adjuvants lowered humoral and cellular responses induced by BA71ΔCD2, consequently decreasing protection against lethal challenge. Further in vitro analyses demonstrated that adjuvant-activated macrophages acquired an antiviral state, limiting LAV replication. These results suggest the hypothesis that reduced vaccine efficacy might result from insufficient antigen production. Overall, the study indicates that combining adjuvants with ASFV-based LAVs would require a fine-tune macrophage activation to enhance functionality without excessively inhibiting viral replication., This research was funded by the Spanish Ministry of Science and Innovation, MICIU/AEI/10.13039/501100011033, grant PID2022-136312OB-I00 (F.R. and J.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the Animal Facility and Clinical and preclinical studies units from IRTA-CReSA for their technical support., info:eu-repo/semantics/publishedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus

  • Tort-Miró, Aida
  • Montaner Tarbes, Sergio
  • Marín-Moraleda, David
  • Muñoz Basagoiti, Jordana
  • Zeng, Yan
  • Navas, María Jesús
  • Muñoz, Marta
  • Monleón, Paula
  • González-Oliver, Judith
  • Martín Mur, Beatriz
  • Caballé, Marc
  • Artigues Cladera, Margalida
  • Esteve-Codina, Anna
  • Aragon, Virginia
  • Vidal, Enric
  • Cobos, Àlex
  • Accensi, Francesc
  • Pina-Pedrero, Sonia
  • Garcia-Fruitos, Elena
  • Rodriguez, Fernando
  • Argilaguet, Jordi
While effective subunit vaccines against African swine fever (ASF) are still under development, live attenuated vaccines (LAVs) remain the only approach capable of inducing robust protective immunity, though biosafety concerns limit their field use. Thus, further research is required to improve LAV safety while maintaining its immunogenicity. Because both the ASF virus (ASFV) and derived LAVs suppress macrophage innate responses, we hypothesized that adjuvants could restore functionality of LAV-infected cells, allowing dose reduction and consequently minimizing the risk of adverse events. To test this, we intranasally vaccinated pigs with a suboptimal dose of the LAV BA71ΔCD2, either alone or combined with two immunostimulatory adjuvants derived from Rothia nasimurium. Both immunostimulants enhanced the in vitro responsiveness of BA71ΔCD2-infected macrophages, which acquired antigen-presenting features. However, in vivo, both adjuvants lowered humoral and cellular responses induced by BA71ΔCD2, consequently decreasing protection against lethal challenge. Further in vitro analyses demonstrated that adjuvant-activated macrophages acquired an antiviral state, limiting LAV replication. These results suggest the hypothesis that reduced vaccine efficacy might result from insufficient antigen production. Overall, the study indicates that combining adjuvants with ASFV-based LAVs would require a fine-tune macrophage activation to enhance functionality without excessively inhibiting viral replication., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus

  • Tort-Miró, Aida
  • Montaner Tarbes, Sergio
  • Marín-Moraleda, David
  • Muñoz Basagoiti, Jordana
  • Zeng, Yan
  • Navas, María Jesús
  • Muñoz, Marta
  • Monleon, Paula
  • González-Oliver, Judith
  • Martín-Mur, Beatriz
  • Caballé, Marc
  • Artigues, Margalida
  • Esteve-Codina, Anna
  • Aragon, Virginia
  • Vidal, Enric
  • Cobos, Àlex
  • Accensi, Francesc
  • Pina-Pedrero, Sonia
  • Garcia-Fruitos, Elena
  • Rodriguez, Fernando
  • Argilaguet, Jordi
While effective subunit vaccines against African swine fever (ASF) are still under development, live attenuated vaccines (LAVs) remain the only approach capable of inducing robust protective immunity, though biosafety concerns limit their field use. Thus, further research is required to improve LAV safety while maintaining its immunogenicity. Because both the ASF virus (ASFV) and derived LAVs suppress macrophage innate responses, we hypothesized that adjuvants could restore functionality of LAV-infected cells, allowing dose reduction and consequently minimizing the risk of adverse events. To test this, we intranasally vaccinated pigs with a suboptimal dose of the LAV BA71ΔCD2, either alone or combined with two immunostimulatory adjuvants derived from Rothia nasimurium. Both immunostimulants enhanced the in vitro responsiveness of BA71ΔCD2-infected macrophages, which acquired antigen-presenting features. However, in vivo, both adjuvants lowered humoral and cellular responses induced by BA71ΔCD2, consequently decreasing protection against lethal challenge. Further in vitro analyses demonstrated that adjuvant-activated macrophages acquired an antiviral state, limiting LAV replication. These results suggest the hypothesis that reduced vaccine efficacy might result from insufficient antigen production. Overall, the study indicates that combining adjuvants with ASFV-based LAVs would require a fine-tune macrophage activation to enhance functionality without excessively inhibiting viral replication., This research was funded by the Spanish Ministry of Science and Innovation, MICIU/AEI/10.13039/501100011033, grant PID2022-136312OB-I00 (F.R. and J.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the Animal Facility and Clinical and preclinical studies units from IRTA-CReSA for their technical support., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus

  • Marín-Moraleda, David
  • Tort-Miró, Aida
  • Ezcurra, Enrique
  • Montaner Tarbes, Sergio
  • Muñoz Basagoiti, Jordana
  • Coatu, Elena
  • Navas, María Jesús
  • Muñoz, Marta
  • Monleon, Paula
  • González-Oliver, Judith
  • Pailler García, Lola
  • Pina-Pedrero, Sonia
  • Accensi, Francesc
  • Rodriguez, Fernando
  • Argilaguet, Jordi
Limited understanding of African swine fever (ASF) immunity remains a major barrier to the rational development of safe and effective vaccines. While antibody-mediated protection is still poorly defined, growing evidence highlights a central role for cellular immunity, particularly cytotoxic cells, as components associated with ASF virus (ASFV) infection control. However, the contribution of individual cytotoxic subsets across different virological and immunological contexts is not well characterized. Here, we investigated cytotoxic responses during BA71ΔCD2 live attenuated vaccine-induced protection and during late-stage lethal ASFV infection. Protective immunity was characterized by antigen-specific cytotoxic T-cell responses, whereas acute ASF was associated with broad cytotoxic activation. Early increases in perforin-positive CD4-CD8αβ+ T cells coincided with the onset of protection, and elevated recall responses correlated with survival following lethal challenge, supporting their association with protective immunity. Additional correlates of protection included CD4+CD8αβ+ cytotoxic T cells, IFNγ-producing cells, and specific antibodies, illustrating the multifactorial nature of protective immunity. In contrast, pigs with acute ASF showed broad cytotoxic expansion, perforin-positive natural killer and γδ T cells showing the strongest association with viremia. Together, these findings advance our understanding of cytotoxic responses to ASFV and identify perforin-positive T cells, alongside complementary immune components, as potential correlates of protection for future vaccine development., This work was funded by the Spanish Ministry of Science and Innovation, MICIU/AEI/10.13039/501100011033, grant PID2022-136312OB-I00 (J.A.)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Cloning and Expression of a Truncated Form of the p72 Protein of the African Swine Fever Virus (ASFV) for Application in an Efficient Indirect ELISA System

  • Cuevas-Romero, Julieta Sandra
  • Zavala-Ocampo, Perla Lucero
  • Pina-Pedrero, Sonia
  • Ganges, Llilianne
  • Muñoz-Aguilera, Adriana
  • García-Cambrón, José Bryan
  • Rodriguez, Fernando
  • Ambagala, Aruna
  • Cerriteño-Sánchez, José Luis
African swine fever (ASF) is a disease that affects both domestic and wild swine. It was recently reported in the Dominican Republic and Haiti (2021), representing a substantial risk to America. The goal of this study was to produce a truncated form of the ASF-p72 recombinant protein based on the ASF strain genotype II (Georgia 2017) as well as to develop and validate a sensitive and specific ASF indirect-ELISA (iELISA) for early detection of ASF. The truncated ASF-p72 recombinant protein was successfully expressed in E. coli BL21/DE3 cells using the pET-SUMO plasmid. Bioinformatics analysis showed 100% homology among the new isolates of ASFV from genotype II. The ASF-p72-truncated protein was used to develop an iELISA, which had a high sensitivity (88%) and strong specificity (97%); the concordance index kappa was K = 0.872, indicating nearly perfect agreement compared to the WOAH confirmatory immunoperoxidase test. The validation results utilizing the reference sera panel from the OIE-ASF Reference Laboratory show the excellent detection capabilities of ASF antibodies up to a 1:1000 serum dilution. The inter-assay coefficient of variation (CV 10.4%) and intra-assay CV (2.8%) data show that the assay is precise and reproducible. This biotechnology advancement can be used to conduct future epidemiological research for ASF surveillance in ASF-free American countries., This research was funded by PROCINORTE Project 2023 (INIFAP-CENID-SAI SIGI 154626612) and the Spanish Ministry of Science and Innovation (grant reference PID2022-136312OB-I00 to F.R.)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Adjuvant-induced macrophage activation compromises BA71ΔCD2-mediated protection against African swine fever virus

  • Tort-Miró, Aida
  • Montaner Tarbes, Sergio
  • Marín-Moraleda, David
  • Muñoz Basagoiti, Jordana
  • Zeng, Yan
  • Navas, María Jesús
  • Muñoz, Marta
  • Monleón, Paula
  • González-Oliver, Judith
  • Martín Mur, Beatriz
  • Caballé, Marc
  • Artigues Cladera, Margalida
  • Esteve-Codina, Anna
  • Aragon, Virginia
  • Vidal, Enric
  • Cobos, Àlex
  • Accensi, Francesc
  • Pina-Pedrero, Sonia
  • Garcia-Fruitos, Elena
  • Rodriguez, Fernando
  • Argilaguet, Jordi
While effective subunit vaccines against African swine fever (ASF) are still under development, live attenuated vaccines (LAVs) remain the only approach capable of inducing robust protective immunity, though biosafety concerns limit their field use. Thus, further research is required to improve LAV safety while maintaining its immunogenicity. Because both the ASF virus (ASFV) and derived LAVs suppress macrophage innate responses, we hypothesized that adjuvants could restore functionality of LAV-infected cells, allowing dose reduction and consequently minimizing the risk of adverse events. To test this, we intranasally vaccinated pigs with a suboptimal dose of the LAV BA71ΔCD2, either alone or combined with two immunostimulatory adjuvants derived from Rothia nasimurium. Both immunostimulants enhanced the in vitro responsiveness of BA71ΔCD2-infected macrophages, which acquired antigen-presenting features. However, in vivo, both adjuvants lowered humoral and cellular responses induced by BA71ΔCD2, consequently decreasing protection against lethal challenge. Further in vitro analyses demonstrated that adjuvant-activated macrophages acquired an antiviral state, limiting LAV replication. These results suggest the hypothesis that reduced vaccine efficacy might result from insufficient antigen production. Overall, the study indicates that combining adjuvants with ASFV-based LAVs would require a fine-tune macrophage activation to enhance functionality without excessively inhibiting viral replication., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Elucidating the Onset of Cross-Protective Immunity after Intranasal Vaccination with the Attenuated African Swine Fever Vaccine Candidate BA71ΔCD2

  • Marín-Moraleda, David
  • Muñoz-Basagoiti, Jordana
  • Tort-Miró, Aida
  • Navas, María Jesús
  • Muñoz, Marta
  • Vidal, Enric
  • Cobos, Àlex
  • Martín-Mur, Beatriz
  • Meas, Sochanwattey
  • Motuzova, Veronika
  • Chang, Chia-Yu
  • Gut, Marta
  • Accensi, Francesc
  • Pina-Pedrero, Sonia
  • Núñez, José Ignacio
  • Esteve-Codina, Anna
  • Gavrilov, Boris
  • Rodriguez, Fernando
  • Liu, Lihong
  • Argilaguet, Jordi
African swine fever (ASF) is a deadly disease of swine currently causing a worldwide pandemic, leading to severe economic consequences for the porcine industry. The control of disease spread is hampered by the limitation of available effective vaccines. Live attenuated vaccines (LAVs) are currently the most advanced vaccine prototypes, providing strong protection against ASF. However, the significant advances achieved using LAVs must be complemented with further studies to analyze vaccine-induced immunity. Here, we characterized the onset of cross-protective immunity triggered by the LAV candidate BA71ΔCD2. Intranasally vaccinated pigs were challenged with the virulent Georgia 2007/1 strain at days 3, 7 and 12 postvaccination. Only the animals vaccinated 12 days before the challenge had effectively controlled infection progression, showing low virus loads, minor clinical signs and a lack of the unbalanced inflammatory response characteristic of severe disease. Contrarily, the animals vaccinated 3 or 7 days before the challenge just showed a minor delay in disease progression. An analysis of the humoral response and whole blood transcriptome signatures demonstrated that the control of infection was associated with the presence of virusspecific IgG and a cytotoxic response before the challenge. These results contribute to our understanding of protective immunity induced by LAV-based vaccines, encouraging their use in emergency responses in ASF-affected areas., This research was funded by the Spanish Ministry of Science and Innovation, MICIU/AEI/10.13039/501100011033, grant PID2022-136312OB-I00 (F.R. and J.A.), and the Swedish Research Council for Sustainable Development (FORMAS), grant 2017-00486 (F.R. and L.L.)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Development and Standardization of Indirect ELISA for African Swine Fever Virus Using Recombinant p30 Protein Produced in Prokaryotic System

  • Cerriteño-Sánchez, José Luis
  • García-Cambrón, José Bryan
  • Zavala-Ocampo, Perla Lucero
  • Ganges, Llilianne
  • Cuevas-Romero, Julieta Sandra
African Swine Fever (ASF), caused by the African Swine Fever Virus (ASFV), is a highly contagious hemorrhagic disease with high mortality (≈100%) in pigs and is considered the most devastating disease to date. Given the importance of this disease, we aimed to assess the use of the recombinant p30 protein as the sole antigen for the development of an accurate and precise ELISA test (iELISA) for the virus. The recombinant p30 protein (rp30) was produced in a bacterial expression system using a SUMO-tagged expression vector. Protein expression was confirmed by Western blot analysis and purified using affinity chromatography. Antigenicity was evaluated in CF-1 mice, which demonstrated the ability to generate high levels of specific antibodies. The rp30 showed a sensitivity of 95.6% when used in the development of iELISA, a specificity of 92.3%, and a kappa index (κ) of 0.836. Furthermore, reference sera (OIE-ASF) were used to validate the assays, and the results demonstrated an excellent capacity to detect ASF antibodies using only the rp30 antigen up to a serum dilution of 1:100. The inter- and intra-assay variability coefficients were 4.27% and 4.85%, respectively, demonstrating that the assay was accurate and reproducible, allowing its use in seroepidemiological analyses for ASF surveillance., This research was funded by PROCINORTE (CENID-Salud Animal e inocuidad/INIFAP grant number: 154626612) and the MICIU (PID2022-136312OBI00)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genetically Distinct African Swine Fever Virus Genotype II Variant in Wild Boar, Spain, 2025–2026

  • Gallardo, Carmina
  • Marcet-Houben, Marina
  • Agüero, Montserrat
  • Nieto, Raquel
  • Casado, Nadia
  • Soler, Alejandro
  • Ruano, María José
  • Villalba, Rubén
  • Fernández-Pinero, Jovita
  • Simón, Alicia
  • Pérez, Covadonga
  • Gómez, Concepción
  • García, Cecilia
  • Labrador, Mireia
  • Argilaguet, Jordi
  • Coronado, Liani
  • Majo, Natalia
  • Aguilera-Sepulveda, Pilar
  • Aldea, Irene
  • Gabaldón, Toni
  • Gómez, María Belén
  • Arias, Marisa
African swine fever virus genotype II was detected in wild boar in Spain in 2025 after >30 years of absence. Whole-genome sequencing and molecular follow-up of 8 representative cases identified a stable 9.8-kb deletion affecting the multigene family in the left variable region, defining an ASFV genotype II variant., This work was supported by the European Union Reference Laboratory for African swine fever (grant no. 101198164, EURL-ASF 2025–2027) and the Spanish Ministry of Science and Innovation (MICIU/AEI/10.13039/501100011033), grant PID2022-136312OB-I00., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Nanoparticle-Based Secretory Granules Induce a Specific and Long-Lasting Immune Response through Prolonged Antigen Release

  • Bosch Camós, Laia
  • Martínez-Torró, Carlos
  • López-Laguna, Hèctor
  • Lascorz, Jara
  • Argilaguet, Jordi
  • Villaverde, Antonio
  • Rodriguez, Fernando
  • Vázquez, Esther
Developing prolonged antigen delivery systems that mimic long-term exposure to pathogens appears as a promising but still poorly explored approach to reach durable immunities. In this study, we have used a simple technology by which His-tagged proteins can be assembled, assisted by divalent cations, as supramolecular complexes with progressive complexity, namely protein-only nanoparticles and microparticles. Microparticles produced out of nanoparticles are biomimetics of secretory granules from the mammalian hormonal system. Upon subcutaneous administration, they slowly disintegrate, acting as an endocrine-like secretory system and rendering the building block nanoparticles progressively bioavailable. The performance of such materials, previously validated for drug delivery in oncology, has been tested here regarding the potential for time-prolonged antigen release. This has been completed by taking, as a building block, a nanostructured version of p30, a main structural immunogen from the African swine fever virus (ASFV). By challenging the system in both mice and pigs, we have observed unusually potent pro-inflammatory activity in porcine macrophages, and long-lasting humoral and cellular responses in vivo, which might overcome the need for an adjuvant. The robustness of both innate and adaptive responses tag, for the first time, these dynamic depot materials as a novel and valuable instrument with transversal applicability in immune stimulation and vaccinology., This project was mainly funded by the proof-of-concept project NANOSWINE, granted by UAB-Generalitat de Catalunya to E.V. and A.V. The authors are indebted to the Agencia Española de Investigación (AEI) for granting projects on the construction of protein materials of clinical interest (PID2019-105416RB-I00/AEI/10.13039/501100011033 and PDC2022-133858-I00 to E.V. and PID2020-116174RB-I00 to A.V.), to AGAUR for project SGR 2021 00092 to A.V., and to the Spanish Ministry of Science and Innovation (grant reference PID2022-136312OB-I00 to FR). C.M.-T. was supported by a Margarita Salas grant from Universitat Autònoma de Barcelona and Ministerio de Universidades (funded by the European Union—NextGenerationEU). We also appreciate the support from CIBER—Consorcio Centro de Investigación Biomédica en Red (CB06/01/0014), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, and Red de Investigación en Sanidad Animal (RISA). A.V. received an ICREA ACADEMIA award. The production of the therapeutic proteins was assisted, in part, by the Protein Production (PPP) Unit of the ICTS Nanbiosis Platform of the CIBER-BBN/IBB (http://www.nanbiosis. es/unit/u1-protein-production-platform-ppp/, accessed on 28 January 2024)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Inactivated Rothia nasimurium promotes a persistent antiviral immune status in porcine alveolar macrophages

  • Tort Miró, Aida
  • Alonso, Uxía
  • Martín-Mur, Beatriz
  • Muñoz Basagoiti, Jordana
  • Zeng, Yan
  • Marín-Moraleda, David
  • Ezcurra, Enrique
  • Montaner Tarbes, Sergio
  • Navas, María J.
  • Muñoz, Marta
  • Monleón, Paula
  • González-Oliver, Judith
  • Cano, Esmeralda
  • Vilalta, Carles
  • Caballé, Marc
  • Criado, Lourdes
  • Kochanowski, Karl
  • Accensi, Francesc
  • Aragon, Virginia
  • Correa-Fiz, Florencia
  • Esteve-Codina, Anna
  • Rodriguez, Fernando
  • Argilaguet, Jordi
Globalization has increased the incidence of infectious diseases in livestock, further aggravated by the reduction of antibiotic usage. To minimize the resulting economic consequences to the meat production industry, as well as the risk of zoonotic events, the use of immunostimulants has emerged as a potential strategy to enhance animal resilience to diseases. In particular, the capability of bacterial-based immunostimulants to modulate innate immune cells functionality makes them cost-effective candidates as vaccine adjuvants, antimicrobials, or preventive immunostimulators inducing long-term innate immune memory in livestock. However, further research is required to identify novel bacterial strains with immunostimulatory properties. Here we characterized in vitro the immunostimulatory properties of Rothia nasimurium isolated from warthog fecal microbiota. Stimulation with heat-inactivated Rothia induced cytokine production by porcine immune cells, and a robust innate immune transcriptomic signature in porcine alveolar macrophages. Interestingly, the bacteria induced inflammasome activation and IL-1β production, thus confirming its pro-inflammatory properties, and suggesting its potential as vaccine adjuvant. Importantly, this immunostimulatory status functionally resulted in an antimicrobial state, enhancing the phagocytic capability of alveolar macrophages, and hampering the replication levels of two major porcine viral pathogens: the porcine reproductive and respiratory syndrome virus (PRRSV) and the African swine fever virus (ASFV). Moreover, macrophages showed an enhanced cytokine response upon ASFV infection several days after heat-inactivated Rothia stimulation, suggesting the induction of an innate immune memory phenotype. This nonspecific response resulted in a significant reduction of ASFV replication kinetics, demonstrating the capacity of the bacteria to induce a more resistant state in macrophages against a virus infection. Altogether, these results demonstrate the immunostimulatory capability of heat-inactivated R. nasimurium in porcine macrophages, showing potential to enhance animal resilience to diseases through the modulation of innate immune cells responsiveness to infections., The author(s) declare that financial support was received for the research and/or publication of this article. This work is part of the projects PDC2021-120987-I00 (FR) and PID2022-136312OB-I00 (FR&JA), both funded by the MCIN/AEI/10.13039/501100011033/FEDER, UE. YZ is supported by a fellowship from the China Scholarship Council Visiting Scholar Program (202305960008). Institutional support to CNAG was provided by the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, and by the Generalitat de Catalunya through the Departament de Salut and the Departament de Recerca i Universitats. KK is supported by funding from the Spanish Ministry of Research and Innovation (RYC2021-033035-I/AEI/10.13039/501100011033)., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nanoparticle-Based Secretory Granules Induce a Specific and Long-Lasting Immune Response through Prolonged Antigen Release

  • Bosch Camós, Laia|||0000-0001-6245-4284
  • Martinez Torro, Carlos|||0000-0002-3529-3355
  • López-Laguna, Hèctor|||0000-0001-5249-8304
  • Lascorz Lozano, Jara A.|||0000-0002-5823-0728
  • Argilaguet, Jordi|||0000-0001-5924-2774
  • Villaverde, Antonio|||0000-0002-2615-4521
  • Rodriguez, Fernando|||0000-0001-7361-8408
  • Vázquez, Esther|||0000-0003-1052-0424
Developing prolonged antigen delivery systems that mimic long-term exposure to pathogens appears as a promising but still poorly explored approach to reach durable immunities. In this study, we have used a simple technology by which His-tagged proteins can be assembled, assisted by divalent cations, as supramolecular complexes with progressive complexity, namely protein-only nanoparticles and microparticles. Microparticles produced out of nanoparticles are biomimetics of secretory granules from the mammalian hormonal system. Upon subcutaneous administration, they slowly disintegrate, acting as an endocrine-like secretory system and rendering the building block nanoparticles progressively bioavailable. The performance of such materials, previously validated for drug delivery in oncology, has been tested here regarding the potential for time-prolonged antigen release. This has been completed by taking, as a building block, a nanostructured version of p30, a main structural immunogen from the African swine fever virus (ASFV). By challenging the system in both mice and pigs, we have observed unusually potent pro-inflammatory activity in porcine macrophages, and long-lasting humoral and cellular responses in vivo, which might overcome the need for an adjuvant. The robustness of both innate and adaptive responses tag, for the first time, these dynamic depot materials as a novel and valuable instrument with transversal applicability in immune stimulation and vaccinology.